CJC-1295
CJC-1295
SKU:EMP-GM-CJC-DAC-5MG
Couldn't load pickup availability
CJC-1295: A Long-Acting GHRH Analog for Advanced Peptide Research
CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analog engineered with a Drug Affinity Complex (DAC) to significantly extend its biological half-life. In controlled research environments, this modification has enabled sustained elevation of growth hormone secretion, making it an important tool in studies requiring prolonged GH stimulation.
Features:
- DAC-Enhanced Half-Life: Allows for sustained GH release over several days
- Consistent Research Formulation: Available as a lyophilized white powder for precise measurement and stability
- Storage Friendly: Easy to store and refrigerate after reconstitution
Research Focus:
CJC-1295 has been studied in preclinical models exploring endocrine function, IGF-1 modulation, and tissue growth support. Its extended half-life via DAC chemistry makes it well-suited for long-acting GH-related research protocols. Comparative studies between DAC and non-DAC versions have provided insights into peptide pharmacokinetics and receptor dynamics.
DAC (Drug Affinity Complex) is a molecular modification that enhances peptide half-life. In the case of CJC-1295:
- With DAC: Half-life ~5–8 days. Dosing frequency: Once or twice per week (research context)
- Without DAC: Half-life ~30 mins. Dosing frequency: 1–2 times daily (short-acting GHRH analog)
🔬 Research Applications
- Long-acting GH and IGF-1 stimulation models
- Muscle maintenance and metabolic signal research
- Anti-aging and regenerative biology studies
🧪 Molecular Details
- CAS Number: 863288-34-0
- Molecular Formula: C165H271N47O46
- Molecular Weight: 3647.9 g/mol
- Form: Lyophilized Powder
- Appearance: White Powder
- Storage: Store in a cool, dry place. Refrigerate after reconstitution.
Batch / Lot Number COAs:
With DAC: EMP-CJC-DAC-250528-A
Without DAC: EMP-CJC-NODAC-250528-A
